Valuation: BlinkLab Limited

Market Cap 9.86Cr 6.85Cr 5.99Cr 5.52Cr 5.11Cr 9.7Cr 653.42Cr 66Cr 26Cr 320.87Cr 26Cr 25Cr 1.11TCr P/E 2026 *
-6.45x
P/E 2027 * -6.45x
Enterprise Value 9.46Cr 6.57Cr 5.75Cr 5.3Cr 4.9Cr 9.3Cr 626.91Cr 63Cr 25Cr 307.86Cr 25Cr 24Cr 1.07TCr EV / Sales 2026 *
291x
EV / Sales 2027 * 639x
Free-Float
80.71%
Yield 2026 *
-
Yield 2027 * -
1 day-5.84%
1 week-2.27%
Current month+4.03%
1 month+4.03%
3 months-22.29%
6 months-25.00%
Current year-20.37%
1 week 0.64
Extreme 0.635
0.72
1 month 0.57
Extreme 0.57
0.72
Current year 0.57
Extreme 0.57
1.07
1 year 0.4
Extreme 0.405
1.1
3 years 0.2
Extreme 0.205
1.1
5 years 0.2
Extreme 0.205
1.1
10 years 0.2
Extreme 0.205
1.1
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/08/2021
Chief Tech/Sci/R&D Officer - 17/08/2021
Corporate Officer/Principal - 17/08/2021
Director TitleAgeSince
Director/Board Member - 18/12/2025
Director/Board Member - 17/08/2021
Chairman - 15/12/2023
Change 5-day change 1-year change 3-year change Capi.($)
-5.84%-2.27%+21.70% - 7.24Cr
+0.27%-1.57%-23.66%+15.83% 2,84800Cr
-2.41%-0.20%-9.84%+691.66% 32TCr
+8.59%+3.34%+321.39%+1,070.32% 13TCr
+3.18%+3.43%+19.52%+64.64% 10TCr
+3.03%+3.32%+88.44%+165.16% 9.29TCr
+2.04%+1.42%-19.53%-0.53% 8.32TCr
+3.61%+5.62%-28.56%+87.99% 6.45TCr
-2.10%-3.49%+1.60%+70.97% 4.67TCr
+2.38%+1.84%-47.10%+35.55% 3.95TCr
Average +1.24%+1.65%+32.39%+244.62% 37.25TCr
Weighted average by Cap. +0.51%+0.60%-6.33%+117.15%

Financials

2026 *2027 *
Net sales 3L 2L 2L 2L 2L 3L 2.15Cr 21.8L 9L 1.06Cr 8L 8L 3.66Cr 1L 1L 88.06T 81.21T 75.14T 1L 96.09L 10L 4L 47.19L 4L 4L 1.63Cr
Net income -60.5L -42L -36.74L -33.88L -31.35L -59.51L -40Cr -4.06Cr -1.59Cr -20Cr -1.58Cr -1.54Cr -68Cr -74L -51.37L -44.94L -41.44L -38.35L -72.78L -49Cr -4.96Cr -1.95Cr -24Cr -1.93Cr -1.89Cr -83Cr
Net Debt -40L -27.77L -24.29L -22.4L -20.73L -39.34L -27Cr -2.68Cr -1.05Cr -13Cr -1.04Cr -1.02Cr -45Cr -60L -41.66L -36.44L -33.6L -31.09L -59.01L -40Cr -4.02Cr -1.58Cr -20Cr -1.56Cr -1.53Cr -68Cr
Logo BlinkLab Limited
BlinkLab Limited is an Australia-based digital healthcare company focused on Artificial intelligence (AI) powered diagnostics. The Company has fully developed a smartphone based diagnostic platform for autism, Attention-Deficit/Hyperactivity Disorder (ADHD), schizophrenia, and other neurodevelopmental conditions. Its product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as over 18 months old. Its pipeline includes BlinkLab Dx 1 and BlinkLab Dx N. Its BlinkLab Dx 1 is an autism diagnostic adjunct. Its BlinkLab Dx N is an ADHD diagnostic adjunct.
Employees
-
Date Price Change Volume
09/26/09 A$0.6450 -5.84% 1,62,208
08/26/08 A$0.6850 -2.14% 46,484
07/26/07 A$0.7000 -1.41% 83,436
06/26/06 A$0.7100 +9.23% 3,79,865
03/26/03 A$0.6500 +0.78% 1,03,243
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.6450AUD
Average target price
1.830AUD
Spread / Average Target
+183.72%

Annual profits - Rate of surprise